UNSPSC 51352208: Diethylstilbestrol dipropionate
Commodity
Code facts
- Part of
-
-
51000000
-
51350000
- 51352200
-
51350000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51352208
| NIGP code |
|---|
| 26968 Hormones and Synthetic Substitutes |
Definition
This classification denotes a non-steroidal estrogen with the molecular formula C24H28O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y98CK3J0OL, chemically known as 4,4-stilbenediol, alpha,alpha-diethyl-, dipropionate, trans- but more generally known as diethylstilbestrol dipropionate, which bears US NIH Compound Identifier 657220. European Medicines Agency schedules Diethylstilbestrol dipropionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32995.
Read the full definition
Most nations, for tariff and trade purposes, schedule diethylstilbestrol dipropionate under HS 29072900. As of Q4 2014, DIETHYLSTILBESTROL DIPROPIONATE remains US FDA's Preferred Term for this commodity. Diethylstilbestrol dipropionate bears US NLM identifiers UMLS ID C0057965 and NCI Concept Code C74557. SMILES: CC/C(=C(/CC)\C1CCC(CC1)OC(=O)CC)/C2CCC(CC2)OC(=O)CC.
About UNSPSC 51352208
UNSPSC 51352208 Diethylstilbestrol dipropionate is a Commodity code for a specific pharmaceutical product, but state and local procurement activity under this code occurs primarily through multistate cooperative purchasing vehicles that aggregate demand for generic pharmaceuticals and over-the-counter products across multiple jurisdictions. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represents the primary issuing body visible in recent activity, procuring on behalf of participating state agencies, counties, and other local government facilities across multiple states including Oregon. Vendors supplying under this code must meet stringent compliance requirements including current Good Manufacturing Practices (cGMP) certification, Drug Supply Chain Security Act (DSCSA) compliance, FDA approval, and comprehensive insurance coverage (commercial general liability of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000). Products must be distributed through authorized wholesalers — AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC — with vendors required to maintain contractual relationships with at least two of the three and support chargeback systems. Pricing flexibility is expected through multiple formats (flat price, net price variants, or WAC-minus structures), and vendors pay a 3 percent administrative fee on all contract purchases while facing performance penalties of $200 to $1,500 per violation.
MMCAP's Request for Proposal issued January 20, 2026 with proposals due March 26, 2026 represents the most recent solicitation under this code. The RFP establishes multiple contracts with a two-year term for new responders (with optional extensions at MMCAP's discretion) and aligns incumbent amendments through June 30, 2028, with awarded vendors required to have products available by May 15, 2026 and agreements effective July 1, 2026. Evaluation is weighted heavily toward price competitiveness (75 percent), with the remaining 25 percent distributed across fixed pricing submission (10 percent), administrative compliance and EDI capability (5 percent each), and agreement to the 3 percent administrative fee structure (5 percent). Submissions are made through the ePro procurement system in Google Chrome using Excel-to-CSV formatted pricing and product information with supporting documentation emailed to MMCAP_Infuse.RFP@state.mn.us. The cooperative purchasing model and multistate scope indicate that opportunities under this code target vendors capable of serving geographically dispersed government facilities with reliable supply chain compliance and wholesale distribution relationships.
Quick answers
What is UNSPSC 51352208?
UNSPSC 51352208 is Diethylstilbestrol dipropionate, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51352208?
UNSPSC 51352208 maps to 1 NIGP code, 26968 Hormones and Synthetic Substitutes.
On GovTribe
See everything under UNSPSC 51352208
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code